Compare Charles River Laboratories Intl. Inc (CRL) vs Block Inc (XYZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Block Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $228.01 (market cap $11.14B), while Block Inc trades at $83.32 (market cap $47.61B). The key difference: Block Inc is far larger — about 4.3× Charles River Laboratories Intl. Inc's market cap, and Block Inc is trading nearer its 52-week high, Charles River Laboratories Intl. Inc nearer its low. Which is the better fit depends on your goals.
| CRL | XYZ | |
|---|---|---|
Market Cap | $11.14B | $47.61B |
Sector | Health | Technology |
52-Week High | $233.60 | $81.11 |
52-Week Low | $145.57 | $49.04 |
Enterprise Value | $14.00B | $42.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
Block (XYZ) trades at $78.72, up 1.84% today, with a bullish technical outlook and strong analyst support (26 buy ratings). Recent earnings beat expectations in Q1 2026, though net income margin narrowed to 3.3% in 2025. The company faces a $45 million settlement over Cash App fraud allegations but continues to invest in AI and Square growth.
The stock offers upside to the $88.53 consensus target, driven by earnings momentum and AI initiatives, but risks include regulatory scrutiny, rising credit losses, and volatile cash flow. Investors should weigh solid long-term growth prospects against near-term execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Block Inc
Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom
Read more on XYZ →
